Vanguard Personalized Indexing Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Vanguard Personalized Indexing Management, LLC

  • $6.09 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$144.95 - $152.29 $11,451 - $12,030
-79 Reduced 1.25%
6,248 $945,000
Q2 2022

Aug 09, 2022
BUY
$83.14 - $145.99 $245,013 - $430,232
2,947 Added 87.19%
6,327 $922,000
Q1 2022

May 16, 2022
BUY
$110.08 - $142.92 $80,908 - $105,046
735 Added 27.79%
3,380 $401,000
Q4 2021

Feb 23, 2022
BUY
$99.73 - $148.48 $36,900 - $54,937
370 Added 16.26%
2,645 $365,000
Q3 2021

Nov 09, 2021
BUY
$98.85 - $138.91 $224,883 - $316,020
2,275 New
2,275 $316,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email